Literature DB >> 7066034

Different molecular forms of fibronectin in rheumatoid synovial fluid.

I Clemmensen, R B Andersen.   

Abstract

The concentration of fibronectin in rheumatoid synovial fluid was found to be 2-3 times higher than in the corresponding plasma. Normal plasma revealed a homogeneous precipitate by cross- immunoelectrophoresis using antifibronectin, while rheumatoid plasma and rheumatoid synovial fluid exhibited a heterogeneous precipitate. The heterogeneous precipitate in rheumatoid plasma was found to be a complex between fibronectin and fibrinogen as evidenced by cross-immunoelectrophoresis. Synovial fluid fibronectin demonstrated a lower molecular weight by gelfiltration on Sepharose CL6B than did normal plasma fibronectin. We suggest that the presence of degraded fibronectin in rheumatoid synovial fluid may be the result of either the degradation of fibrin-fibronectin complexes or the destruction of matrix fibronectin from the synovial tissue.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7066034     DOI: 10.1002/art.1780250104

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  35 in total

1.  Relative sialylation and fucosylation of synovial and plasma fibronectins in relation to the progression and activity of rheumatoid arthritis.

Authors:  Magdalena Przybysz; Dorota Maszczak; Krzysztof Borysewicz; Jacek Szechiński; Iwona Katnik-Prastowska
Journal:  Glycoconj J       Date:  2007-07-03       Impact factor: 2.916

Review 2.  The roles of catabolic factors in the development of osteoarthritis.

Authors:  Dominick J Blasioli; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2013-12-11       Impact factor: 6.389

3.  Studies on fibronectin in inflammatory vs non-inflammatory polymorphonuclear leucocytes of patients with rheumatoid arthritis. I. Immunofluorescent and flow cytometric analysis.

Authors:  A D Beaulieu; M Audette; C Menard; C Parent; M Duval
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

4.  Plasma fibronectin in psoriatic arthritis subgroups.

Authors:  M Cutolo; S Accardo; M A Cimmino; S Rovida
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

5.  Disease-associated extracellular matrix suppresses osteoblastic differentiation of human periodontal ligament cells via MMP-1.

Authors:  Jeena Joseph; Yvonne L Kapila; Takayuki Hayami; Sunil Kapila
Journal:  Calcif Tissue Int       Date:  2009-12-02       Impact factor: 4.333

6.  Distribution and biosynthesis of connective tissue components by synovial fibroblasts cultured with mononuclear inflammatory cells.

Authors:  J Heino; H Larjava; V C Duance; R Penttinen
Journal:  Br J Exp Pathol       Date:  1986-10

7.  Fibronectin in chronic inflammation: studies using the rat air pouch model of chronic allergic inflammation.

Authors:  D L Scott; M W Robinson; S Yoshino
Journal:  Br J Exp Pathol       Date:  1985-10

8.  Differences between the early and advanced stages of rheumatoid arthritis in the expression of EDA-containing fibronectin.

Authors:  Magdalena Przybysz; Krzysztof Borysewicz; Iwona Katnik-Prastowska
Journal:  Rheumatol Int       Date:  2009-02-11       Impact factor: 2.631

9.  Carbohydrate heterogeneity of fibronectins. Synovial fluid fibronectin resembles the form secreted by cultured synoviocytes but differs from the plasma form.

Authors:  S Carsons; B B Lavietes; A Slomiany; H S Diamond; E Berkowitz
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

10.  The influence of fixation and tissue preparation on the immunohistochemical demonstration of fibronectin in human tissue.

Authors:  B Hølund; P P Clausen; I Clemmensen
Journal:  Histochemistry       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.